NanOlogy
  • Home
  • About
  • Technology
  • Development
    • Investigational Drugs
    • Pipeline
    • Clinical Trials
    • Partnering Opportunities
  • News & Publications
    • Recent News Highlights
    • Press Release Archives
    • NanOlogy In the News
    • Presentations & Publications Archive
  • Contact Us
    • Partnering Opportunities
    • Physicians and Patients
Post placeholder image
October 16, 2017 in NanOlogy in the News

Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery

NanOlogy 0 Like Post Comments Off on Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery
Read More
Post placeholder image
October 16, 2017 in NanOlogy in the News

Journal for Clinical Studies: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer

NanOlogy 0 Like Post Comments Off on Journal for Clinical Studies: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer
Read More
Post placeholder image
October 16, 2017 in NanOlogy in the News

Drug Delivery: NanOlogy takes nanoparticle tech into phase 2 trials.

NanOlogy 0 Like Post Comments Off on Drug Delivery: NanOlogy takes nanoparticle tech into phase 2 trials.
Read More
Post placeholder image
October 10, 2017 in NanOlogy in the News

PBR: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer

NanOlogy 0 Like Post Comments Off on PBR: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer
Read More
Post placeholder image
October 3, 2017 in NanOlogy in the News

Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK

NanOlogy 0 Like Post Comments Off on Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK
Read More
Post placeholder image
September 18, 2017 in NanOlogy in the News

DFB Pharmaceuticals Forms NanOlogy & Soria for Clinical Development of Naked Nanoparticle Platform

NanOlogy 0 Like Post Comments Off on DFB Pharmaceuticals Forms NanOlogy & Soria for Clinical Development of Naked Nanoparticle Platform
Read More
Post placeholder image
September 17, 2017 in NanOlogy in the News

Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment

NanOlogy 0 Like Post Comments Off on Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment
Read More
Post placeholder image
September 17, 2017 in NanOlogy in the News

‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers

NanOlogy 0 Like Post Comments Off on ‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers
Read More
Post placeholder image
September 17, 2017 in NanOlogy in the News

DFB Pharmaceuticals Forms NanOlogy™

NanOlogy 0 Like Post Comments Off on DFB Pharmaceuticals Forms NanOlogy™
Read More
Post placeholder image
September 17, 2017 in NanOlogy in the News

DFB Pharmaceuticals Forms NanOlogy™ for Clinical Development of Naked Nanoparticle Platform to Treat Cancer and Related Illnesses

NanOlogy 0 Like Post Comments Off on DFB Pharmaceuticals Forms NanOlogy™ for Clinical Development of Naked Nanoparticle Platform to Treat Cancer and Related Illnesses
Read More
Prev12Next
NanOlogy

NanOlogy investigational drugs have not yet been proven to be safe and effective in accordance with the requirements of the U.S. FDA and are not approved by FDA or any other jurisdiction for commercial distribution. NanOlogy, NanoPac, and NanoDoce are trademarks of NanOlogy, LLC.    Purcision is a trademark to CritiTech, Inc.  © NanOlogy LLC      Legal